Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000082011 | SCV000225054 | pathogenic | not provided | 2013-03-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000082011 | SCV000617297 | pathogenic | not provided | 2023-05-03 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 19557870, 15792869, 25525159, 17951086, 30932294, 35599849, 32796131, 32906206) |
Labcorp Genetics |
RCV000792332 | SCV000931620 | pathogenic | Eichsfeld type congenital muscular dystrophy | 2024-12-09 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg439*) in the SELENON gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SELENON are known to be pathogenic (PMID: 21131290, 21670436). This variant is present in population databases (rs377215510, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with multiminicore disease and autosomal recessive congenital myopathy (PMID: 15792869, 19557870). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 95958). For these reasons, this variant has been classified as Pathogenic. |
Centre for Mendelian Genomics, |
RCV001197254 | SCV001367891 | pathogenic | See cases | 2016-01-01 | criteria provided, single submitter | clinical testing | This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PS1,PM2. |
Mayo Clinic Laboratories, |
RCV000082011 | SCV001713798 | pathogenic | not provided | 2019-07-22 | criteria provided, single submitter | clinical testing | PVS1, PM2, PM3 |
Revvity Omics, |
RCV000792332 | SCV002020061 | pathogenic | Eichsfeld type congenital muscular dystrophy | 2019-07-23 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000792332 | SCV002511858 | pathogenic | Eichsfeld type congenital muscular dystrophy | 2022-04-07 | criteria provided, single submitter | clinical testing | Variant summary: SELENON c.1315C>T (p.Arg439X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 2.8e-05 in 247460 control chromosomes. c.1315C>T has been reported in the literature in individuals affected with Eichsfeld Type Congenital Muscular Dystrophy or similar disease. These data indicate that the variant may be associated with disease. Five clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. |
Broad Center for Mendelian Genomics, |
RCV000792332 | SCV003761177 | pathogenic | Eichsfeld type congenital muscular dystrophy | 2023-01-24 | criteria provided, single submitter | curation | The p.Arg439Ter variant in SELENON has been reported in 3 individuals with SELENON-RM (PMID: 15792869, 19557870, 30932294), segregated with disease in 1 affected relative from 1 family (PMID: 17951086), and has been identified in 0.00988% (3/30354) of South Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs377215510). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID#: 95958) and has been interpreted as pathogenic by multiple submitters. Of the 3 affected individuals, 1 of those was a homozygote, which increases the likelihood that the p.Arg439Ter variant is pathogenic (PMID: 30932294). This nonsense variant leads to a premature termination codon at position 439 which is predicted to lead to a truncated or absent protein. Loss of function of the SELENON gene is an established disease mechanism in autosomal recessive SELENON-RM. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive SELENON-RM. ACMG/AMP Criteria applied: PVS1, PM2_supporting, PM3_supporting (Richards 2015). |
Fulgent Genetics, |
RCV000792332 | SCV005655212 | pathogenic | Eichsfeld type congenital muscular dystrophy | 2024-04-24 | criteria provided, single submitter | clinical testing |